Thrombocytopenia — Trials, FDA Actions & Pivotal Research

20 active Thrombocytopenia trials currently recruiting in the US, sourced from ClinicalTrials.gov.

Synced daily from openFDA and ClinicalTrials.gov. Last sync: June 12, 2026.

Recruiting trials by city

Cities where Thrombocytopenia trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.

Aurora, CO Birmingham, AL Boston, MA

Active Thrombocytopenia trials

Currently recruiting US trials matching Thrombocytopenia, sourced live from ClinicalTrials.gov. We’ll add per-event articles here as those trials post results or hit primary completion.

Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia.

for Thrombocytopenia

Sponsor: Nicolas Brogly

Sex: Female·Age: 18+

Code: NCT07616349·Recruiting

Apply to this trial

Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)

for Thrombocytopenia

Sponsor: Zhejiang Cancer Hospital

Sex: All·Age: 12 - 65

Code: NCT07441720·Phase 2·Recruiting

Apply to this trial

Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT

for Hematopoietic Stem Cell Transplantation

Sponsor: First Affiliated Hospital of Zhejiang University

Sex: All·Age: 18 - 70

Code: NCT07442513·Phase 3·Recruiting

Apply to this trial

Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children

for Romiplostim N01

Sponsor: Assiut University

Sex: All·Age: Up to 18

Code: NCT07214025·Not Yet Recruiting

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

for Immune Thrombocytopenia (ITP)

Sponsor: argenx

Sex: All·Age: 12 - 17

Code: NCT07194850·Phase 2, Phase 3·Recruiting

Apply to this trial

Herombopag Treated T-DM1 Induced Platelet Reduction

for Thrombocytopenia

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Sex: All·Age: 18 - 75

Code: NCT07257809·Phase 2·Recruiting

Apply to this trial

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

for Solid Tumor Malignancies, Cancer

Sponsor: Jun wang

Sex: All·Age: 18 - 80

Code: NCT07185893·Not Yet Recruiting

Hematological Disorders in EHPVO Patients

for Extrahepatic Portal Vein Obstruction (EHPVO)

Sponsor: Rahab Nady

Sex: All·Age: 18 - 75

Code: NCT07108023·Not Yet Recruiting

Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)

for Thrombocytopenia

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Sex: All·Age: 18 - 75

Code: NCT07110090·Phase 1·Recruiting

Apply to this trial

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

for Immune Thrombocytopenia (ITP)

Sponsor: Climb Bio, Inc.

Sex: All·Age: 18+

Code: NCT07043946·Phase 1, Phase 2·Recruiting

Apply to this trial

Neonatal Platelet Transfusion Threshold Trial

for Thrombocytopenia

20 locations incl. Birmingham

Sponsor: NICHD Neonatal Research Network

Sex: All·Age: 1 Hour - 48 Hours·Accepts healthy volunteers

Code: NCT06676904·Recruiting

Apply to this trial

Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury

for Acute Kidney Injury

1 location in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 85

Code: NCT06349577·Recruiting

Apply to this trial

The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP

for Thrombocytopenia

Sponsor: Shandong University

Sex: All·Age: 18+

Code: NCT06913374·Phase 2, Phase 3·Not Yet Recruiting

Luspatercept for Clonal Cytopenias of Uncertain Significance

for CCUS Clonal Cytopenia of Undetermined Significance

1 location in New York

Sponsor: Weill Medical College of Cornell University

Sex: All·Age: 18+

Code: NCT06788691·Phase 2·Recruiting

Apply to this trial

Apixaban in Thrombocytopenia

for Deep Vein Thrombosis

1 location in Boston

Sponsor: Rushad Patell

Sex: All·Age: 18+

Code: NCT06886516·EARLY_Phase 1·Recruiting

Apply to this trial

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

for Acute Myeloid Leukemia

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sex: All·Age: 18 - 60

Code: NCT06245746·Phase 1·Recruiting

Apply to this trial

Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery

for Thrombocytopenia

Sponsor: Anhui Provincial Hospital

Sex: All·Age: 18+

Code: NCT06673498·Phase 2·Recruiting

Apply to this trial

Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilepsy

for Neutropenia

Sponsor: Assiut University

Sex: All·Age: 18 - 60·Accepts healthy volunteers

Code: NCT06491303·Not Yet Recruiting

Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia

for Thrombocytopenia

Sponsor: The Third People's Hospital of Chengdu

Sex: All·Age: 18+

Code: NCT06562738·Phase 4·Recruiting

Apply to this trial

Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT

for Thrombocytopenia

Sponsor: Peking University People's Hospital

Sex: All·Age: 18 - 65

Code: NCT06202625·Phase 2, Phase 3·Recruiting

Apply to this trial